GLP-1RA use associated with lower obesity-related cancer risk in meta-analysis of adults with T2DM/obesity
Large review finds link between GLP-1 drugs and lower obesity-related cancer risk
A systematic review and meta-analysis of 3,960,974 adults with type 2 diabetes and/or obesity found GLP-1RA use was associated with a signif…
A large review of studies involving nearly 4 million adults with type 2 diabetes or obesity found that using GLP-1 receptor agonists was ass…
Meta-analysis finds 8.33% pooled prevalence of new-onset diabetes after SARS-CoV-2 infection in adults
Study finds link between COVID-19 infection and new diabetes diagnoses in adults
A systematic review and meta-analysis of 33 observational studies in adults following SARS-CoV-2 infection found a pooled prevalence of new-…
About 8.3% of adults develop new diabetes after COVID-19 infection, with type 2 cases making up most of the diagnoses in a review of 33 stud…
Retrospective study of semaglutide in 17 patients with type 2 diabetes and end-stage renal disease
Can a diabetes drug help people with kidney failure? A small study looks for clues
A retrospective cohort study of 17 adults with T2DM and ESRD (including those on hemodialysis) found descriptive reductions in HbA1c (-0.31%…
A small study found that injectable semaglutide helped adults with kidney failure lose an average of 12.6 kilograms while reducing insulin n…
Systematic review maps gut microbiome–epigenetic crosstalk in obesity and type 2 diabetes
What's happening in your gut that might affect your weight and blood sugar?
A systematic review and bibliometric analysis of over 1,100 documents identified three major epigenetic domains involved in gut microbiome c…
Gut bacteria changes linked to obesity and type 2 diabetes may influence genetic switches, with research in this area growing nearly 28% ann…
mHealth program reduces caregiver burden for dementia-diabetes caregivers in RCT
Can a smartphone app ease the crushing burden of caring for a loved one with both dementia and diabetes?
A 12-week mHealth supportive care program for family caregivers of individuals with dementia and type 2 diabetes significantly reduced careg…
A smartphone app helped family caregivers feel significantly less burdened and more supported while caring for a loved one with both dementi…
Colchicine reduces arterial stiffness in high-risk T2D patients: RCT
Could a common anti-inflammatory drug help protect the hearts of people with diabetes?
In a 26-week RCT of 100 high-risk patients with type 2 diabetes, colchicine 0.5 mg daily significantly reduced arterial stiffness (MAP-adjus…
A low-dose anti-inflammatory drug called colchicine may help keep arteries flexible and protect heart health in people with type 2 diabetes …
Web Portal Use in Type 2 Diabetes: Uptake Driven by Intentions, Not Frequency
Why Do Some Patients with Diabetes Use Health Apps More Than Others?
In a secondary analysis of an RCT, higher education, openness, and intentions regarding physical activity and nutrition significantly increa…
Higher education and a strong desire to eat healthy drove diabetes patients to use health apps, while just wanting to improve health wasn't …
High Infection Rates in Type 2 Diabetes: Periodontitis Prevalence at 33.6%
Are Infections Hitting People with Type 2 Diabetes Harder Than We Thought?
This meta-analysis found severe periodontitis prevalence at 33.6% (95% CI: 23.7-44.2) and lower respiratory tract infection incidence at 140…
People with type 2 diabetes face higher rates of severe gum disease and frequent lung infections, making infection prevention a critical par…